Assessment of non‐surgical versus surgical therapy for localized hepatocellular carcinoma

Localized hepatocellular carcinoma (HCC) in patients with adequate liver function is typically treated with resection. Non‐surgical modalities including trans‐arterial embolization have emerged as options for intermediate/advanced HCC. Hypothesizing that non‐surgical techniques have expanded to localized disease, we examined treatment patterns, factors associated with surgical therapy, and the impact of modality on survival.

[1]  R. Swan,et al.  Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection. , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[2]  Chia-Yang Hsu,et al.  Surgical Resection Is Better than Transarterial Chemoembolization for Hepatocellular Carcinoma Beyond Milan Criteria Independent of Performance Status , 2014, Journal of Gastrointestinal Surgery.

[3]  J. Jakobsen,et al.  Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. , 2013, The Cochrane database of systematic reviews.

[4]  Rebecca M. Dodson,et al.  Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study. , 2013, Journal of the American College of Surgeons.

[5]  A. Benson,et al.  Treatment Trends and Predictors of Adjuvant and Neoadjuvant Therapy for Gastric Adenocarcinoma in the United States , 2013, Annals of Surgical Oncology.

[6]  W. Chow,et al.  Variation in lymph node examination after esophagectomy for cancer in the United States. , 2012, Archives of surgery.

[7]  M. Choti,et al.  National trends in surgical procedures for hepatocellular carcinoma: 1998‐2008 , 2012, Cancer.

[8]  E. Ward,et al.  Persistent disparities in liver transplantation for patients with hepatocellular carcinoma in the United States, 1998 through 2007 , 2011, Cancer.

[9]  S. Lipsitz,et al.  Cost implications of the rapid adoption of newer technologies for treating prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Wetterslev,et al.  Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. , 2011, The Cochrane database of systematic reviews.

[11]  D. Flum,et al.  Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma. , 2010, Journal of the American College of Surgeons.

[12]  B. Gray,et al.  Racial and ethnic differences in the use of high-volume hospitals and surgeons. , 2010, Archives of surgery.

[13]  M. Choti,et al.  Predictors of Survival After Resection of Early Hepatocellular Carcinoma , 2009, Annals of surgery.

[14]  T. Pawlik,et al.  Surgical Management of Early-Stage Hepatocellular Carcinoma: Resection or Transplantation? , 2008, Journal of Gastrointestinal Surgery.

[15]  C. Ko,et al.  The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States , 2008, Annals of Surgical Oncology.

[16]  M. Choti,et al.  Racial and Geographic Disparities in the Utilization of Surgical Therapy for Hepatocellular Carcinoma , 2007, Journal of Gastrointestinal Surgery.

[17]  C. Ko,et al.  National Failure to Operate on Early Stage Pancreatic Cancer , 2007, Annals of surgery.

[18]  R. Brook,et al.  Disparities in the utilization of high-volume hospitals for complex surgery. , 2006, JAMA.

[19]  W. Lau,et al.  A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.

[20]  J. Bruix,et al.  Prognostic prediction and treatment strategy in hepatocellular carcinoma , 2002, Hepatology.

[21]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[22]  A. Stewart,et al.  The National Cancer Data Base report on treatment patterns for hepatocellular carcinomas , 2000, Cancer.

[23]  Daan Brandenbarg.  The National. , 1892 .

[24]  W. Al-Refaie,et al.  Who receives their complex cancer surgery at low-volume hospitals? , 2012, Journal of the American College of Surgeons.

[25]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.